We hypothesized that, in myeloma patients, proinflammatory cytokine tumor necrosis factor-alpha (TNF-α) upregulates the production of interleukin-6 (IL-6), which then mediates increased secretion of MCP-1. Here, IL6 is linked to plasma cell myeloma.